DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 5.60% to $1.18 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.56% to 26,186.41 and Dow Jones Industrial Average falling 0.29% to 52,421.20.
This was the stock's fifth consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 56.62% below its 52-week high of $2.72, which the company reached on December 17th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.28% to $266.32, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ remained unchanged.
Trading volume (3.3 M) remained 803,447 below its 50-day average volume of 4.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.